Description
BRINEURA® (cerliponase alfa) is a prescription medication used to slow loss of ability to walk or crawl (ambulation) in pediatric patients with neuronal ceroid lipofuscinosis type 2 (CLN2 disease), also known as tripeptidyl peptidase 1 (TPP1) deficiency.
Additional information
| Brand | BRINEURA® |
|---|---|
| Generic name | Cerliponase alfa for injection |
| Form | Parenteral |
| Strength | 150mg |
| Packing | 2*150mg |
| Manufacturer | BioMarin Pharmaceutical |
| Documents | Either PO or prescription |
| Storage | 2-8°C temperature |
Reviews
There are no reviews yet.